Nowadays, with the development of the Internet, breast cancer patients like to go online for information related to their disease, and with it comes inner anxiety and fear. Especially for triple negative breast cancer patients, they are worried when they see the above mentioned poor prognosis on the internet. In fact, many breast cancer patients do not have to be so worried and afraid. I would like to tell breast cancer patients the following questions: 1. How to understand the concept of triple negative breast cancer. Currently, ER-negative/PR-negative/Her2-negative is defined as “triple negative” and most hospitals determine it by immunohistochemistry. It must be clear that the criteria for determining ER, PR, and Her2 negative may be different from hospital to hospital. If a patient has an ER positivity rate of 8%, hospital A may determine it as negative and hospital B may determine it as positive. 2. The poor prognosis of triple negative breast cancer is a “statistical” concept. We were the first in the world to report the first paper on the prognosis of triple-negative breast cancer, and it did attract a lot of attention from breast cancer experts around the world. I did the statistical analysis myself, so I can tell you that the prognosis of triple negative breast cancer is not one-to-one, and your own prognosis is not necessarily poor, and your concern may be totally unnecessary. The abstract of the paper is as follows: 3. The prognosis of a breast cancer patient is influenced by many factors, and “triple negative” is not the only determinant. In addition, even if the original prognosis is poor, standardized treatment can improve the prognosis. Therefore, patients with true triple negative disease should not be overly worried.